[1]
Sodruddin, G., Rahman, M.M., Habib, S.A., Chowdhury, M.T., Bashar, A., Hoque, M.H., Chowdhury, A.W., Akter, N., Hossain, S.M.Z. and Banerjee, S.K. 2020. Rivaroxaban versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients with Non-Valvular Atrial Fibrillation. University Heart Journal. 16, 2 (Oct. 2020), 99–105. DOI:https://doi.org/10.3329/uhj.v16i2.49666.